The Journal of Advanced Diabetes Research is at the vanguard of international scientific advancement, committed to reshaping the future of diabetes knowledge and care. More than an archive of learned writing, this peer-reviewed journal is a forum of cooperation, a shining light of innovation, and an accelerator of positive change in clinical practice and public health policy. We gather researchers, clinicians, educators, and advocates in a shared purpose: the elimination of the burdens of diabetes through serious research, innovative problem-solving, and the unrestricted dissemination of findings that serve people and societies.
Established with a strong dedication to scientific integrity and patient influence, the Journal of Advanced Diabetes Research covers the entire range of diabetes research. Our editorial team and authors represent a broad range of disciplines, from endocrinology and genetics to pharmacology, nutrition, behavioral health, and preventive medicine. Our multidisciplinary approach enables us to tackle tough issues from many sides, creating synergies that drive breakthroughs and accelerate research translation into actionable solutions. Transparency, accountability, and ethical stewardship are core values-standards that guide every phase from submission to publishing.
Our goal is to raise the voices of concerned thinkers and problem-solvers working day and night in diabetes research globally. We aim to publish research and commentaries that question the mechanisms behind diabetes, streamline therapeutic approaches, and shed light on upcoming trends in epidemiology, diagnostics, and technology. We picture a future where diabetes is not a life-shortening disease, but one that can be predicted, avoided, and controlled with personalized, evidence-based treatment.
The Journal hopes to be the intellectual driver of this change. Through each issue, article, and review, we try to inspire a questioning mind, challenge assumptions, and encourage debate across geographic, cultural, and disciplinary divides. Together, we create a community of trailblazers who are committed to envisioning a different way of thinking about, addressing, and eventually defeating diabetes.
Insulin resistance, Type 1 diabetes, Type 2 diabetes, Gestational diabetes, Hyperglycemia, Hypoglycemia, Pancreatic beta cells, Insulin sensitivity, Glucose metabolism, Glycemic control, Diabetic ketoacidosis, HbA1c, Glucose tolerance test, Diabetic neuropathy, Diabetic retinopathy, Diabetic nephropathy, Insulin therapy, Oral hypoglycemics, Continuous glucose monitoring, Artificial pancreas, Metabolic syndrome, Obesity and diabetes, Adipose tissue, Inflammation and diabetes, Oxidative stress, Hyperinsulinemia, Glucagon, C-peptide, Diabetes complications, Cardiovascular disease and diabetes, Diabetes epidemiology, Genetics of diabetes, Diabetes prevention, Lifestyle intervention, Dietary management, Physical activity and diabetes, Insulin secretion, Beta cell dysfunction, Insulin signaling pathway, Glucose uptake, Diabetes biomarkers, Diabetic foot ulcer, Advanced glycation end products (AGEs), Islet transplantation, Beta cell regeneration, Diabetes and immune response, Autoimmune diabetes, Diabetes and microbiome, Hormonal regulation, Glucose homeostasis, Diabetes and depression, SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, Diabetes and kidney disease, Insulin pump therapy, Postprandial glucose, Insulin analogs, Diabetes and aging, Diabetes and pregnancy, Bariatric surgery and diabetes, Diabetes self-management, Diabetes education, Telemedicine in diabetes, Hypoglycemia unawareness, Diabetes and cognitive function, Diabetes-related inflammation, Diabetes and cancer risk, Personalized medicine in diabetes, Diabetes phenotypes, Monogenic diabetes, Neonatal diabetes, Diabetes clinical trials, Insulin gene expression, Beta cell apoptosis, Glucose transporters, Diabetic cardiomyopathy, Mitochondrial dysfunction in diabetes, Diabetes and lipid metabolism, Insulin receptor substrate, Diabetic autonomic neuropathy, Microvascular complications, Macrovascular complications, Diabetes and sleep disorders, Diabetes and mental health, Reactive oxygen species, Endothelial dysfunction, Insulin resistance mechanisms, Diabetes screening, Diabetes in children, Diabetes in elderly, Insulin clearance, Beta cell mass, Diabetes and epigenetics, Glucose variability, Hypoglycemic agents, Diabetes and inflammation markers, Diabetes remission, Diabetic wound healing, Diabetes and oxidative phosphorylation, Etc..